4.4 Review

Artificial intelligence in breast imaging

期刊

CLINICAL RADIOLOGY
卷 74, 期 5, 页码 357-366

出版社

W B SAUNDERS CO LTD
DOI: 10.1016/j.crad.2019.02.006

关键词

-

资金

  1. National Institute for Health Research
  2. Cambridge School of Clinical Medicine, Frank Edward Elmore Fund
  3. Medical Research Council's Doctoral Training Partnership [1966157]
  4. EPSRC Centre for Mathematical and Statistical Analysis of Multimodal Clinical Imaging [EP/N014588/1]
  5. EPSRC [EP/N014588/1] Funding Source: UKRI
  6. MRC [1966157] Funding Source: UKRI

向作者/读者索取更多资源

This article reviews current limitations and future opportunities for the application of computer-aided detection (CAD) systems and artificial intelligence in breast imaging. Traditional CAD systems in mammography screening have followed a rules-based approach, incorporating domain knowledge into hand-crafted features before using classical machine learning techniques as a classifier. The first commercial CAD system, ImageChecker M1000, relies on computer vision techniques for pattern recognition. Unfortunately, CAD systems have been shown to adversely affect some radiologists' performance and increase recall rates. The Digital Mammography DREAM Challenge was a multidisciplinary collaboration that provided 640,000 mammography images for teams to help decrease false-positive rates in breast cancer screening. Winning solutions leveraged deep learning's (DL) automatic hierarchical feature learning capabilities and used convolutional neural networks. Start-ups Therapixel and Kheiron Medical Technologies are using DL for breast cancer screening. With increasing use of digital breast tomosynthesis, specific artificial intelligence (AI)-CAD systems are emerging to include iCAD's PowerLook Tomo Detection and ScreenPoint Medical's Transpara. Other Al-CAD systems are focusing on breast diagnostic techniques such as ultrasound and magnetic resonance imaging (MRI). There is a gap in the market for contrast-enhanced spectral mammography Al-CAD tools. Clinical implementation of Al-CAD tools requires testing in scenarios mimicking real life to prove its usefulness in the clinical environment. This requires a large and representative dataset for testing and assessment of the reader's interaction with the tools. A cost-effectiveness assessment should be undertaken, with a large feasibility study carried out to ensure there are no unintended consequences. Al-CAD systems should incorporate explainable Al in accordance with the European Union General Data Protection Regulation (GDPR). (C) 2019 The Royal College of Radiologists. Published by Elsevier Ltd. All rights reserved.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.4
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据